# Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease

> clinical trial · VERIFIED · 2026-06-11

Status: NOT_YET_RECRUITING · Sponsor: Lingyi Biotech Co., Ltd. · Condition: Wilson's Disease

- Company: Lingyi Biotech Co., Ltd.
- Sector: rare disease
- Primary source: https://clinicaltrials.gov/study/NCT07641140

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.